Telehealth licensure requirements, DEA controlled substance prescribing rules, NJ PDMP registration requirements, and compliance checklist for physicians practicing telehealth in New Jersey. Verified May 2026.
| Telehealth-specific license | ✓ Not required — standard license |
| IMLC compact pathway | ✓ Yes — IMLC member |
| Informed consent | ✓ Not required |
| Audio-only permitted | ✓ Permitted |
| Medicaid parity | ✓ Yes — parity in effect |
| Out-of-state registration | ✓ Not required |
| Telehealth prescribing | ✓ Permitted |
| Prior in-person visit | ✓ Not required |
| DEA special registration | ✓ Not required |
| Schedule II (stimulants, opioids) | ✓ Permitted |
| Buprenorphine (MAT) | ✓ Permitted |
| Stimulants (ADHD) | ✓ Permitted |
| Benzodiazepines | ✓ Permitted |
| Program name | NJ PDMP |
| Registration required | Required before prescribing |
| Required for schedules | Schedule II–V |
No — New Jersey does not require a separate telehealth-specific license. A standard New Jersey medical license covers telehealth practice.
Yes — New Jersey is an IMLC member. Eligible physicians can obtain a New Jersey license through the compact's expedited pathway using their State of Principal License.
Yes — telehealth prescribing is permitted in New Jersey. No prior in-person visit is currently required under active DEA telehealth extensions. COVID-era DEA telehealth prescribing extension in effect; permanent rule pending
Yes — New Jersey requires physicians to register with the NJ PDMP before prescribing Schedule II–V controlled substances. Must query NJ PDMP before prescribing Schedule II–V
Yes — New Jersey permits audio-only (phone) telehealth encounters without video.
Add New Jersey to your tracked states. Set renewal reminders. Get email alerts when telehealth rules or DEA prescribing requirements change. 14-day free trial, no credit card.
StateLicensure is a regulatory research platform — not a legal service. Data is sourced from official state boards, DEA, and CMS, and updated as rules change. For compliance decisions with regulatory consequences, confirm requirements directly with your state board.
